You are here

Global

Climate change analysis: Half of all global food threatened by growing water crisis -report estimates

Thu, 2024-10-17 10:32 — mike kraft

The world has a worsening water crisis and half of all food production will be at risk of failure by the middle of this century.

That’s the worrying message from a report released Wednesday by a major international study.

Country / Region Tags:

General Topic Tags:

Extreme Weather

Problem, Solution, SitRep, or ?:

Climate change finance needed to help developing countries could reach 'hundreds of billions'--U.N. group

Wed, 2024-10-16 10:29 — mike kraft

Climate change finance could land at 'hundreds of billions', COP29 leaders say Negotiators will meet in Baku next month to agree on a new financing goal. Gloria Dickie,Nailia Bagirova Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Novavax's trial of combo COVID-flu shot put on hold because of safety concerns

Wed, 2024-10-16 09:56 — mike kraft

US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax's trial of combo COVID-flu shot put on hold because of safety concerns
Log in or register to post comments

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

Wed, 2024-10-16 09:41 — mike kraft

3 doses of mRNA COVID vaccine show advantage against severe outcomes The authors said COVID-19 infection can result in a "brainstem insult" that results in clusters of physical long-COVID symptoms. CIDRAP

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Three doses of mRNA COVID vaccine show advantage against severe outcomes --study
Log in or register to post comments

Information on the COVID-19 XEC variant that is now circulating in the US.

Wed, 2024-10-16 09:32 — mike kraft

COVID-19 XEC variant is now circulating in the US. Here's what you should know about it. COVID-19 XEC variant is now circulating in the US. Here is what you need to know about the strain. Ahjané Forbes USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Information on the COVID-19 XEC variant that is now circulating in the US.
Log in or register to post comments

COVID rapid test guidance: When to take them and do they actually expire

Tue, 2024-10-15 10:07 — mike kraft

Rapid tests: When to take them and do they actually expire? There are some rapid tests you might be able to take past the expiration date on the box. Here’s what to know. Gina Cook, Erika Gonzalez, News4 Anchor/Reporter, Patricia Fantis NBC4 Washington

...

According to Covid.gov, people should take an at-home test when:

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about COVID rapid test guidance: When to take them and do they actually expire
Log in or register to post comments

RSV: Researchers pinpoint markers of more severe cases among children

Tue, 2024-10-15 09:55 — mike kraft

Inside RSV: Researchers pinpoint markers of more severe cases Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children ... Brigham and Women’s Hospital Medical Xpress

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children experience only mild symptoms while others suffer from severe disease are not well understood.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about RSV: Researchers pinpoint markers of more severe cases among children
Log in or register to post comments

Risk of new type 2 diabetes in kids higher after COVID than other respiratory infections --study

Tue, 2024-10-15 09:38 — mike kraft

Risk of new type 2 diabetes in kids higher after COVID than other respiratory infections, data suggest The authors said COVID-19 infection can result in a "brainstem insult" that results in clusters of physical long-COVID symptoms. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Risk of new type 2 diabetes in kids higher after COVID than other respiratory infections --study
Log in or register to post comments

Bird flu: CDC checking to see if existing vaccines are well matched for current virus.

Tue, 2024-10-15 09:26 — mike kraft

CDC probes if bird flu mutations impact vaccine stockpile The Centers for Disease Control and Prevention is investigating whether the U.S. stockpile of bird flu vaccines is still well matched to the virus after discovering recent mutations. Medical Xpress

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Bird flu: CDC checking to see if existing vaccines are well matched for current virus.
Log in or register to post comments

Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases

Mon, 2024-10-14 10:59 — mike kraft

WHO approves Bavarian Nordic's mpox vaccine for adolescents The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disease that has triggered global concern. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Mpox: WHO approves a vaccine for adolescents, Zimbabwe reports first cases
Log in or register to post comments

Pages

Page loaded in 1.529 seconds.